Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines
Yi He Ling, Tianhong Li, Ziqiang Yuan, Missak Haigentz, Thomas K. Weber, Roman Perez-Soler
Dive into the research topics of 'Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines'. Together they form a unique fingerprint.